Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioIVT Acquires BSC | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BioIVT Acquires BSC

BSC has been a supplier of human blood products and components to the life sciences research community for more than 37 years

By: Betsy Louda

, Contract Pharma

BioIVT has acquired Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community for more than 37 years. BSC is headquartered in Colmar, PA, with two additional FDA-registered donor centers in Allentown, PA and Reading, PA.
 
“We are delighted that BSC is joining BioIVT,” said BioIVT chief executive officer, Jeff Gatz. “BSC brings a decades-long reputation for top-notch quality, compliance and customer service. BSC’s capabilities will enable BioIVT to provide same-day fresh material to the biotech industry in the Northeast Corridor. BSC also significantly strengthens BioIVT’s immunology business line, enabling BioIVT to provide a full range of blood-derived cells and cellular products ranging from leukopak-derived peripheral blood mononuclear cells (PBMCs) to CD34 stem cells.” 
 
“In BioIVT, we have found a like-minded partner whose desire to provide the highest quality research samples and top-notch customer service equals our own,” added BSC chief executive officer Jeff Widdoss. “Together, we will be able to help our clients accelerate their drug discovery and immunotherapy research.”
 
Emphasizing its commitment to providing the highest quality biospecimens, BSC’s donors are all screened according to AABB guidelines, and its research blood products all undergo the complete battery of FDA-required infectious disease state tests.
 
BioIVT will retain BSC’s three locations and all of its employees. Financial details about this transaction were not disclosed.

 
 
 
 
 
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics